Receptor-mediated drug delivery of bispecific therapeutic antibodies through the blood-brain barrier
Therapeutic antibody drug development is a rapidly growing sector of the pharmaceutical industry. However, antibody drug development for the brain is a technical challenge, and therapeutic antibodies for the central nervous system account for ∼3% of all such agents. The principal obstacle to antibod...
Saved in:
Published in | Frontiers in Drug Delivery Vol. 3 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
Frontiers Media S.A
10.07.2023
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!